Australia’s PEP, Carlyle Group team up for iNova Pharmaceuticals bid
Australia's Pacific Equity Partners has teamed up with US private equity major Carlyle Group in a joint bid for iNova Pharmaceuticals that is expected to be worth about A$1 billion ($765.1...To view the full article, register now.
Already a subscriber? Click here to view full article